|
New content on this website from the last 20 days.
Meetings
- Meetings and Conferences:
Others: Validation programs often experience delays not because of technical challenges, but because documentation gaps can create uncertainty, rework and misalignment across teams. Effective documentation pr
Accelerate CQV & Compliance: Why Documentation Quality Drives Operational Readiness
Xtalks — The Life Science Community™, Online webinar
2026-11-11
- Meetings and Conferences:
Microbiology / Virology: Early-stage oncology development is increasingly global. For emerging biopharma, the goal is not simply to expand into more countries, but to build a development strategy that identifies the right mar
Accelerating Early-Stage Oncology Global Drug Development: Connecting West to East
Xtalks — The Life Science Community™, Online webinar
2026-11-19
- Meetings and Conferences:
Microbiology / Virology: For neurodegenerative disease clinical trials, understanding how a condition is progressing and whether a treatment is having an effect can be difficult using traditional assessments alone. Biomarker
From Detection to Decisions: Biomarkers in Neurodegenerative Disease
Xtalks — The Life Science Community™, Online webinar
2026-11-10
- Meetings and Conferences:
Others: As the biologics landscape becomes increasingly complex and therapeutic modalities grow more sophisticated, potency assay strategies are evolving from regulatory requirements into powerful tools that
Potency Assays for Modern Biologics: Expert Insights and Future Trends
Xtalks — The Life Science Community™, Online webinar
2026-11-11
- Meetings and Conferences:
Others: Artificial Intelligence (AI) is rapidly transforming biometrics functions across the clinical trial lifecycle, from protocol design and statistical analysis planning to programming, data standardizati
AI Governance in Clinical Trial Biometrics: A Practical Framework for Small-Mid Size Organization
Xtalks — The Life Science Community™, Online webinar
2026-11-19
- Meetings and Conferences:
Others: Early-phase clinical trials operate under compressed timelines, complex protocols, narrow eligibility criteria and limited patient populations, making even small delays disproportionately costly. For
Accelerate Biotech Patient Recruitment with Smarter Site Selection
Xtalks — The Life Science Community™, Online webinar
2026-11-17
- Meetings and Conferences:
Microbiology / Virology: Executing clinical trials in complex glomerular diseases require moving beyond traditional functional involvement. As treatment paradigms and regulatory expectations for surrogate endpoints evolve, in
Navigating the Evolving Landscape of Glomerular Disease Clinical Trials
Xtalks — The Life Science Community™, Online webinar
2026-11-16
- Meetings and Conferences:
Others: As biopharmaceutical programs advance under increasingly compressed timelines, upstream development teams face pressure to deliver optimized, quality-targeted processes earlier. Early decisions still
Accelerate Upstream Process Development Using Hybrid Modeling
Xtalks — The Life Science Community™, Online webinar
2026-11-17
- Meetings and Conferences:
Cancer Research: Oncology innovation is accelerating across therapeutic modalities, precision medicine, biomarkers and artificial intelligence. But as scientific possibilities expand, the growing challenge for sponsor
Oncology Drug Development in 2026: From Scientific Innovation to Global Execution (Broadcast 2)
Xtalks — The Life Science Community™, Online webinar
2026-10-06
- Meetings and Conferences:
Others: Sterile drug product fill-finish is where years of development either pay off or unravel. Partnering with a CDMO that has isolator lines does not guarantee success. The difference lies in the depth of
Fill-Finish Success: From Isolator Qualification to GMP Production
Xtalks — The Life Science Community™, Online webinar
2026-11-03
- Meetings and Conferences:
Others: Enzyme replacement therapies have transformed the treatment landscape for many rare genetic and metabolic disorders by addressing enzyme deficiencies that drive disease progression. By supplying a fun
Enzyme Therapy Manufacturing: Preserving Activity Through Production
Xtalks — The Life Science Community™, Online webinar
2026-11-12
- Meetings and Conferences:
Others: Psychiatric drug development still leans on rating scales developed decades ago: subjective instruments that capture how a patient describes feeling but not what the brain is doing. In major depressiv
Can Objective Brain Measures Improve MDD Trial Decisions?
Xtalks — The Life Science Community™, Online webinar
2026-11-12
- Meetings and Conferences:
Others: Early-phase neuroscience trials have traditionally focused primarily on establishing safety and tolerability. From Alzheimer's disease to psychiatry, early development strategies can also generate mea
Lessons Learned in Neuroscience Drug Development: How Biomarker-based, Evidence-driven Decisions Enable Successful Outcomes
Xtalks — The Life Science Community™, Online webinar
2026-11-10
- Meetings and Conferences:
Microbiology / Virology: Cell and gene therapies (CGTs) present unique development challenges, from novel manufacturing processes and delivery methods to complex nonclinical programs and evolving regulatory expectations. For
FDA Meetings: Engaging Regulators Throughout Cell and Gene Therapy Development
Xtalks — The Life Science Community™, Online webinar
2026-11-12
- Meetings and Conferences:
Microbiology / Virology: Therapeutic antibodies are a rapidly growing class of drugs. Their application areas are not only limited to the standard immunoglobulin G (IgG) format but can also be extended to novel formats, inclu
Platform Selection and Development Strategies for High-Performance Anti-Idiotype Antibody Development – in Just 9 Weeks
Xtalks — The Life Science Community™, Online webinar
2026-11-17
- Meetings and Conferences:
Others: Decisions made early in the drug development process from preclinical through Phase IIa can disproportionately impact later development as costs increase with each phase. Timely information quantifyin
Use PET and MRI Imaging Methods Early to Reduce Drug Development Risk
Xtalks — The Life Science Community™, Online webinar
2026-12-15
- Meetings and Conferences:
Others: Successful biologics programs depend on making the right decisions at the right stage of development. Early choices in cell culture strategy, media and feed optimization, downstream recovery, analytic
Reduce Biologics Development Risk Across the Product Life Cycle
Xtalks — The Life Science Community™, Online webinar
2026-11-18
- Meetings and Conferences:
Microbiology / Virology: The diabetes clinical trial landscape is evolving rapidly. As type 1 diabetes programs expand and innovative therapies, including cell and gene therapies, move into clinical development, sponsors face
Advancing Diabetes Clinical Trials Through Integrated Technology and Operational Oversight
Xtalks — The Life Science Community™, Online webinar
2026-11-09
- Meetings and Conferences:
Microbiology / Virology: In vivo CAR-T therapy requires durable, yet transient CAR expression coupled with efficient, T cell-specific delivery. This webinar will focus on how innovations in RNA design and next-generation lipi
Advances in mRNA & LNP technology for in vivo CAR-T therapy
Xtalks — The Life Science Community™, Online webinar
2026-11-05
- Meetings and Conferences:
Others: Paediatric and adolescent obesity trials are now an established part of drug development, but major evidence gaps remain when translating findings across age groups. Regulatory architecture, including
Improve Paediatric Obesity Trials with Evidence-Based Design
Xtalks — The Life Science Community™, Online webinar
2026-11-06
- Meetings and Conferences:
Others: Liquid biopsy has made it possible to detect and characterize cancer from a blood sample, with much of the field focused on circulating tumor DNA (ctDNA). Detection in early-stage disease remains chal
Beyond ctDNA: EVPs and the Future of Early Cancer Detection
Xtalks — The Life Science Community™, Online webinar
2026-11-09
- Meetings and Conferences:
Others: Bispecific antibodies have emerged as a rapidly growing biologic modality that can engage two distinct biological targets within a single molecule. Their unique mechanisms of action have created new o
Manufacturing Bispecific Antibodies: Development & Scale-Up
Xtalks — The Life Science Community™, Online webinar
2026-10-26
- Meetings and Conferences:
Others: Biological processes are shaped by changes across multiple molecular layers, including RNA and proteins, with no single layer telling the whole story. Integrating complementary modalities can provide
Maximize Tissue Insights with Spatial Transcriptomics and Proteomics
Xtalks — The Life Science Community™, Online webinar
2026-11-05
- Meetings and Conferences:
Others: As pet parents increasingly seek proactive solutions to support their pets' quality of life and longevity, brands are under pressure to deliver effective, clinically substantiated pet health products
Formulate Pet Health Products to Improve Aging, Mobility and Immunity
Xtalks — The Life Science Community™, Online webinar
2026-10-22
- Meetings and Conferences:
Others: Lyophilization has become an important development and commercialization strategy for modern parenteral products, including biologics, antibody-drug conjugates, mRNA-lipid nanoparticles, viral vectors
Lyophilization by Design: Improve Stability and Accelerate Scale-Up (Broadcast 2)
Xtalks — The Life Science Community™, Online webinar
2026-11-26
- Meetings and Conferences:
Others: Lyophilization has become an important development and commercialization strategy for modern parenteral products, including biologics, antibody-drug conjugates, mRNA-lipid nanoparticles, viral vectors
Lyophilization by Design: Improve Stability and Accelerate Scale-Up (Broadcast 1)
Xtalks — The Life Science Community™, Online webinar
2026-11-03
- Meetings and Conferences:
Others: Clinical trials succeed or fail at the intersection of two communities: patients who volunteer their time and participation and sites that dedicate resources, expertise and empathy to guide them throu
Build Patient-Site Trust to Improve Clinical Trial Retention
Xtalks — The Life Science Community™, Online webinar
2026-11-02
Companies
|
|